EFFECTS AND CLINICAL SIGNIFICANCE OF PROGLUMIDE IN GASTRIN-STIMULATING CELL PROLIFERATION ON HUMAN COLON CELL LINE SW480
	    		
		   		
		   			
		   		
	    	
    	 
    	10.3781/j.issn.1000-7431.2001.02.004
   		
        
        	
        		- VernacularTitle:丙谷胺抑制人结肠癌细胞株SW480增殖的机制研究
 
        	
        	
        	
        		- Author:
	        		
		        		
		        		
			        		Bin XIE
			        		
			        		;
		        		
		        		
		        		
			        		Shuangwu HE
			        		
			        		;
		        		
		        		
		        		
			        		Daike WANG
			        		
			        		
		        		
		        		
		        		
		        		
		        		
			        		
			        		
		        		
	        		
        		 
        	
        	
        	
        		- Publication Type:Journal Article
 
        	
        	
            
            
            	- From:
	            		
	            			Tumor
	            		
	            		 2001;(2):88-90
	            	
            	
 
            
            
            	- CountryChina
 
            
            
            	- Language:Chinese
 
            
            
            	- 
		        	Abstract:
			       	
			       		
				        
				        	Objective To investigate the role and clinical significance of proglumide (PGL) in gastrin-stimulating cell proliferation on human colon cell line SW480.Methods Effects of proglumide on the viable cell count (A value), IP3 (CPM value), [Ca2+]i and PKC activity of human colon cell line SW480 were evaluated in vitro by MTT assay, 3H-myo-inositol incorporation, fluorescence measurements and γ-32P-ATP incorporation. Results The results showed that A value of PGL+PG group is lower than that of PG or control group (P<0.01 in both groups); The concentration of IP3 or [Ca2+]i in PGL+PG group is lower than that in PG group (P<0.05). Conclusion These results indicate effects of proglumide may be through the phosphoinositide signalling pathway on gastrin-stimulating cell proliferation in human colon cell line SW480. It will provide an experimental evidence for antisingnal transduction therapy for patients with colon cancer.